An extension study to phase IIb dose-finding study of entacapone in patients with Parkinson's disease with end-of-dose wearing-off.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Entacapone (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Novartis
- 28 Nov 2007 Status changed from in progress to completed.
- 30 Aug 2006 New trial record.